Skip to content

Short- term effects of a single bout of moderate physical activity on liver fat content and validation of ultrasonography method after exercise

Short- term effects of a single bout of moderate physical activity on liver fat content and validation of ultrasonography method after exercise - Short- term effects of exercise on liver fat content

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON34197
Enrollment
16
Registered
2010-07-14
Start date
2010-08-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fatty liver NAFLD

Interventions

Intervention Bicycle ergometry The volunteers need to complete 60 minutes of bicycle ergometry at 55% of their predetermined Vo2 max, RER values will also be used to control the intensity

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: BMI 28- 35 Waist circumference >= 88 cm (women), >=102 cm (men)

Exclusion criteria

Exclusion criteria: unstable glyceamic control Thiazolidinediones as hypoglycaemic drug excessive alcohol consumption >2 units or more for men per day and 1 units or more for women per day medication, known to cause steatosis: amiodarone, perhexiline, and DH known liver disease cardiac β-blockers advanced pulmonary or cardiovascular disease orthopedic limitations standard contraindications to exercise testing metallic implants (joint replacement, artificial heart valve, clips) cardiac pacemaker any implanted device (e.g. insulin pump, drug infusion device) claustrophobic

Design outcomes

Primary

MeasureTime frame
Liver fat content - Visceral and subcutaneous fat content - Liver enzymes, lipid profile

Secondary

MeasureTime frame
Body weight, waist circumference, hip circumference - BMI - VO2 max

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)